NCT01501578
- Conditions
- Fibrosis, Lung Diseases, Lung Diseases, Interstitial, +4 more
- Locations
-
- Louis Pradel Hospital (Bâtiment A4) Lyon, France
Clinical trial condition
Pulmonary Fibrosis
Explore clinical trials studying Pulmonary Fibrosis. Study availability and eligibility vary by location and protocol.
127 public trials
25 recruiting studies
Pulmonary Fibrosis trial results
NCT01916577
- Conditions
- COPD, Chronic Disease, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +15 more
- Locations
-
- University of Colorado Hospital Aurora, Colorado, United States
NCT00001596
- Conditions
- Albinism, Albinism, Oculocutaneous, Amino Acid Metabolism, Inborn Errors, +29 more
- Locations
-
- National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States
Completed
Specimen Collection for Individuals With Lung Disease Associated With Rheumatoid Arthritis
NCT00001884
- Conditions
- Arthritis, Arthritis, Rheumatoid, Autoimmune Diseases, +15 more
- Locations
-
- Boston University Boston, Massachusetts, United States
Completed
Identification of Genes Associated With Lung Disease in Patients With Rheumatoid Arthritis
NCT00001885
- Conditions
- Arthritis, Arthritis, Rheumatoid, Autoimmune Diseases, +22 more
- Locations
-
- National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States
Completed
Safety Study of Oral Pirfenidone in Patients With Pulmonary Fibrosis/Idiopathic Pulmonary Fibrosis
NCT00080223
- Conditions
- Fibrosis, Idiopathic Pulmonary Fibrosis, Lung Diseases, +5 more
- Locations
-
- Phoenix, Arizona, United States
- Pomona, California, United States
- San Jose, California, United States
- New Haven, Connecticut, United States
NCT02510937
- Conditions
- Fibrosis, Lung Diseases, Lung Diseases, Interstitial, +4 more
- Locations
-
- Tampa General Hospital Tampa, Florida, United States
- LaPorte County Institute for Clinical Research, Inc Michigan City, Indiana, United States
- University of Pittsburgh Pittsburgh, Pennsylvania, United States
- Vanderbilt University Medical Center Nashville, Tennessee, United States
NCT01417156
- Conditions
- Fibrosis, Lung Diseases, Lung Diseases, Interstitial, +4 more
- Locations
-
- Boehringer Ingelheim Investigational Site Himeji, Hyogo, Japan
- Boehringer Ingelheim Investigational Site Sakai, Osaka, Japan
- Boehringer Ingelheim Investigational Site Seto, Aichi, Japan
- Boehringer Ingelheim Investigational Site Yokohama, Kanagawa, Japan
NCT00352482
- Conditions
- Cardiovascular Diseases, Fibrosis, Hypertension, +9 more
- Locations
-
- UCLA Pulmonary Outpatient Clinic, Los Angeles, California, United States
Completed
Safety and Efficacy of BIBF 1120 at High Dose in Idiopathic Pulmonary Fibrosis Patients II
NCT01335477
- Conditions
- Fibrosis, Lung Diseases, Lung Diseases, Interstitial, +4 more
- Locations
-
- 1199.34.10078 Boehringer Ingelheim Investigational Site Scottsdale, Arizona, United States
- 1199.34.10086 Boehringer Ingelheim Investigational Site San Francisco, California, United States
- 1199.34.10093 Boehringer Ingelheim Investigational Site Santa Barbara, California, United States
- 1199.34.10077 Boehringer Ingelheim Investigational Site Stanford, California, United States